Approval · Notice of Compliance 10824 · 2009
PALLADIA: Notice of Compliance 10824
Issued December 1, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10824
- Date
- December 1, 2009
- Company
- Pfizer Canada Inc., Animal Health GroupKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Antineoplastic
Products in this notice
Medicinal ingredients
- TOCERANIB PHOSPHATE 10 MG per TAB
- TOCERANIB PHOSPHATE 15 MG per TAB
- TOCERANIB PHOSPHATE 50 MG per TAB